Research-Based Benefits of Amrit Kalash

Asthomap: A Potent Ayurvedic Remedy for Bronchial Asthma

Asthomap has emerged as a highly effective ayurvedic formulation for managing bronchial asthma. Clinically tested at S.K Government Ayurveda College in Kurukshetra, Haryana, and AIIMS, New Delhi, Asthomap has shown remarkable curative properties with an excellent safety profile.

Key Findings from Clinical Research

1. High Curability Rate: Asthomap demonstrated an impressive curability rate of up to 90% in patients with bronchial asthma after just 30 days of treatment. This highlights its potential as a powerful therapeutic option for those suffering from this chronic respiratory condition.

2. Superior Efficacy: Asthomap's efficiency is 90% higher than Praval Pisthi and 30% more effective than Svas Kuthar-ras, both of which are established treatments for asthma. This superior efficacy underscores Asthomap's advanced formulation and potent therapeutic benefits.

3. Symptom Alleviation: Asthomap is particularly effective in alleviating key symptoms of bronchial asthma. It significantly reduces svas krichhta (difficulty in breathing) and kasa (bronchial discomfort while lying down), providing much-needed relief to patients. These benefits contribute to an overall improvement in quality of life for individuals with asthma.

The trial conducted at AIIMS showed a significant improvement in symptoms like cough, breathlessness and wheezing (p=0.004).

4. No Side Effects: One of the most significant advantages of Asthomap is its safety profile. The clinical trials reported no side effects, making it a safe alternative to conventional asthma treatments, which often come with various adverse effects.

Conclusion

Asthomap represents a breakthrough in the natural management of bronchial asthma. Its high curability rate, superior efficacy compared to other ayurvedic treatments, and ability to alleviate critical asthma symptoms make it a valuable addition to asthma therapy. The absence of side effects further enhances its appeal, offering patients a safe and effective solution for their respiratory health. With Asthomap, individuals suffering from bronchial asthma can achieve significant relief and improved breathing, leading to a better quality of life.

Glucomap: A Breakthrough in Diabetes Management

Glucomap, a novel therapeutic formulation, has been rigorously tested through four significant clinical studies. These include a double-blind, placebo-controlled trial conducted at the All India Institute of Medical Sciences (AIIMS), New Delhi, a pilot study conducted at King George's Medical University (KGMU), Lucknow, and two additional clinical studies independently verifying its efficacy. These studies collectively underscore Glucomap's effectiveness in managing blood glucose levels and improving overall metabolic health.

Key Findings from Clinical Trials

The clinical trials revealed several important outcomes. Firstly, there was a notable reduction in fasting and postprandial glucose levels. Specifically, fasting glucose levels decreased from a mean of 167 ± 1.22 mg/dl to 131 ± 20 mg/dl, while postprandial (PP) glucose levels also showed significant improvement.

Additionally, there was a marked improvement in Hemoglobin A1c (HbA1c) levels, which reduced from 10.3 ± 2.8 to 8.5 ± 1.49 within three months of Glucomap intake. This demonstrates the potential of Glucomap to improve long-term glycemic control in diabetic patients.

3. Symptom Alleviation: Asthomap is particularly effective in alleviating key symptoms of bronchial asthma. It significantly reduces svas krichhta (difficulty in breathing) and kasa (bronchial discomfort while lying down), providing much-needed relief to patients. These benefits contribute to an overall improvement in quality of life for individuals with asthma.

Furthermore, the trials indicated a significant decrease in triglyceride levels. Triglycerides were reduced from 200.3 ± 37.3 mg/dl to 180.3 ± 28.2 mg/dl in three months, and further to 147.5 ± 27.5 mg/dl in six months. This suggests that Glucomap not only helps in managing blood glucose levels but also contributes to better lipid profile management.

Efficacy in Uncontrolled Diabetes

Notably, Glucomap demonstrated remarkable effectiveness in lowering blood sugar levels even in patients who had previously exhibited uncontrolled glucose levels despite optimal doses of Oral Hypoglycemic Agents (OHA). This highlights its potential as a highly effective treatment option in conjunction with OHAs.

Conclusion

Glucomap stands out as a promising solution in the realm of diabetes management. Its ability to significantly reduce fasting and postprandial glucose levels, HbA1c, and triglycerides, along with its efficacy in patients with uncontrolled diabetes, makes it a valuable addition to current therapeutic options. These findings pave the way for further research and potential widespread clinical application, offering hope to millions of individuals managing diabetes.

Raktda: A Holistic Ayurvedic Solution for Anemia Management

Raktda is a clinically proven ayurvedic formulation designed for the effective management of anemia. Supported by two clinical studies, Raktda has demonstrated its efficacy in increasing hemoglobin levels in patients suffering from anemia. Additionally, it is safe for use in non-anemic individuals to maintain optimal hemoglobin levels.

Clinical fndings:

1. Hemoglobin Level Improvement: Clinical studies have shown that Raktda significantly increases hemoglobin levels (9.23 to 11.04 points within 30 days) in anemic patients, bringing them back to normal ranges. This makes it a reliable treatment option for those struggling with anemia.

2. Safe for Maintenance Use: Raktda is not only effective for treating anemia but also safe for use by non-anemic individuals. It helps maintain healthy hemoglobin levels, making it a versatile supplement for overall well-being..

3. Symptom Relief: In addition to improving hemoglobin levels, Raktda has been found to alleviate several common symptoms associated with anemia. These include fatigue, pain, and anorexia, thereby enhancing the quality of life for those affected by this condition.

4. Enhanced Nutrient Absorption: Raktda is a holistic combination of calcinated iron, processed calcium, micro-nutrients, minerals, and herbs. This unique blend not only provides essential nutrients but also enhances the absorption of iron, calcium, and other micronutrients from regular food intake. This synergistic effect ensures better overall nutrition and improved health outcomes.

Conclusion

Raktda stands out as a comprehensive solution for anemia management. Its ability to increase hemoglobin levels, relieve symptoms of anemia, and enhance nutrient absorption makes it a powerful tool in promoting better health. Whether used for treating anemia or maintaining optimal hemoglobin levels, Raktda offers a safe, effective, and holistic approach to managing this common health issue.

Amlant: A Natural Solution for Acidity Relief

Amlant is an effective natural acidity regulator, clinically proven to alleviate symptoms of acidity. Supported by robust clinical trials, Amlant offers a potent and reliable alternative to conventional acidity medications.

Key Findings from Clinical Research

1. Potency Equivalent to Ranitidine: A study conducted at AIIMS, New Delhi demonstrated that Amlant's effectiveness in relieving acidity is comparable to that of ranitidine, a widely used conventional drug. This establishes Amlant as a viable natural alternative for managing acidity.

2. Rapid and Complete Symptom Relief: Amlant has shown a remarkable 100% efficacy rate in relieving acidity symptoms within just two weeks of starting therapy. Patients reported no recurrence of acidity symptoms after this period, highlighting Amlant's lasting impact and effectiveness.

3. Efficacy in Non-Ulcer Dyspepsia: Amlant is particularly effective in cases of non-ulcer dyspepsia, a condition where even H2 receptor antagonists, proton pump inhibitors, and antacids often fail to provide relief. This underscores Amlant's unique capability to address challenging digestive issues that conventional treatments may not effectively manage.

Conclusion

Amlant emerges as a powerful natural remedy for managing acidity and related symptoms. Its clinical efficacy, comparable to ranitidine, combined with its ability to provide complete and lasting relief within two weeks, makes it a standout option for those suffering from acidity. Additionally, Amlant's effectiveness in treating non-ulcer dyspepsia further enhances its value as a comprehensive solution for digestive health. With Amlant, patients can achieve significant relief from acidity without the side effects commonly associated with conventional medications.

Lipomap: A Natural Remedy for Hyperlipidemia

Lipomap has emerged as an effective natural remedy for patients suffering from hyperlipidemia, a condition characterized by elevated levels of lipids in the blood. This formulation stands out for its safety and efficacy, as demonstrated in a clinically proven double-blind, placebo-controlled trial conducted at the All-India Institute of Medical Sciences (AIIMS).

Key Findings from Clinical Research

The research findings on Lipomap are noteworthy. The trial suggested that Lipomap's potency in increasing high-density lipoprotein (HDL) cholesterol is equivalent to that of lovastatin, a commonly prescribed statin. This makes Lipomap a valuable natural alternative for improving HDL levels, which are beneficial for heart health.

Moreover, Lipomap has shown superior efficacy in lowering triglyceride levels. Patients using Lipomap experienced a 13% reduction in triglycerides, a statistically significant improvement (P=0.01). This reduction is critical for managing hyperlipidemia and reducing the risk of cardiovascular diseases.

In addition to its effects on HDL and triglycerides, Lipomap also demonstrated a significant decrease in total cholesterol and low-density lipoprotein (LDL) levels. Over a period of 12 weeks, patients saw their total cholesterol decrease from approximately 239 mg/dL to 229 mg/dL, and their LDL levels drop from 161.9 mg/dL to 155.2 mg/dL (P=0.004). These changes are significant and contribute to overall cardiovascular health.

Safety Profile

One of the most compelling advantages of Lipomap is its safety profile. Unlike many other medications for dyslipidemia, Lipomap is free from any side effects. This makes it an attractive option for patients seeking a natural and safe alternative to conventional lipid-lowering drugs.

Conclusion

Lipomap offers a promising natural solution for the management of hyperlipidemia. Its ability to increase HDL levels, significantly lower triglycerides, and reduce total cholesterol and LDL levels within 12 weeks, without any side effects, underscores its potential as a valuable treatment option. These findings support Lipomap's role in improving lipid profiles and enhancing cardiovascular health, providing hope for patients seeking effective and safe management of hyperlipidemia.

Livomap: A Natural Solution for Nonalcoholic Fatty Liver Disease (NAFLD)

Nonalcoholic fatty liver disease (NAFLD) is increasingly becoming a prevalent and challenging condition, especially among individuals who do not consume alcohol. This disease, characterized by the accumulation of excess fat in the liver, can lead to serious health complications if not managed properly.

Livomap, an ayurvedic formulation, has emerged as a promising treatment for NAFLD. Clinically tested, Livomap has shown to cure the disease without any adverse effects, providing a natural and safe alternative for liver health.

Key Findings from Clinical Research: Conducted at AIIMS, New Delhi

The research on Livomap has demonstrated its significant benefits for liver health. Daily intake of Livomap for four months has been shown to improve liver health by preventing the deposition of excess fat and reducing the fat already deposited in the liver. This improvement is statistically significant (p<0.01), highlighting Livomap's efficacy in addressing the core issue of fat accumulation in NAFLD.

Furthermore, Livomap has proven to be highly effective in alleviating symptoms associated with NAFLD. Over 95% of patients reported complete relief from abdominal pain after using Livomap (p<0.02). This indicates a substantial improvement in the quality of life for those suffering from this condition.

In addition to these benefits, Livomap has also shown a significant reduction in triglyceride levels. Patients experienced a decrease in triglycerides from 165 mg/dL to 140 mg/dL over three months (p<0.02). This reduction is crucial as elevated triglycerides are often associated with fatty liver disease and other metabolic disorders.

Conclusion

Livomap represents a groundbreaking natural solution for managing and potentially reversing nonalcoholic fatty liver disease. Its ability to prevent and reduce liver fat deposition, relieve abdominal pain, and lower triglyceride levels makes it a valuable therapeutic option. These clinical findings support the potential for Livomap to be a widely accepted treatment, offering hope and improved health outcomes for individuals battling NAFLD.

Worryfree: Effective Relief for Generalized Anxiety Disorder

Worryfree has been clinically validated as an effective treatment for generalized anxiety disorder (GAD), supported by a double-blind, placebo-controlled pilot study conducted at the University of California, San Diego, USA.

Key Findings from Clinical Study

Effectiveness in Anxiety Reduction: The study demonstrated that Worryfree significantly reduces symptoms of generalized anxiety disorder. Within three months of treatment, patients experienced a remarkable reduction in anxiety symptoms, showing improvement by two-fold compared to the placebo group. There was a marked reduction in salivary cortisol levels (stress hormone) by 1.5 times than before within the same period.

Reduction in Worry and Nervousness: Worryfree effectively targets symptoms such as worry and nervousness, which are characteristic of generalized anxiety disorder. By addressing these symptoms, Worryfree contributes to alleviating the emotional burden and improving overall quality of life for individuals with anxiety disorders.

Conclusion

Worryfree emerges as a promising therapeutic option for individuals suffering from generalized anxiety disorder. Backed by rigorous clinical research, Worryfree's ability to significantly reduce anxiety symptoms and alleviate worry and nervousness underscores its efficacy in promoting mental health. With its proven effectiveness and targeted approach to anxiety management, Worryfree offers hope and relief to those seeking a safe and reliable treatment for GAD.

Vidyarthi Amrit: Enhancing Memory and Concentration

Vidyarthi Amrit stands out as a potent brain tonic clinically researched to improve memory and concentration. The formulation has been rigorously studied, including a randomized double-blind placebo-controlled trial conducted at MSAE, Iowa, which highlighted its significant benefits.

Key Findings from Clinical Research

IQ Enhancement: The clinical trial demonstrated that Vidyarthi Amrit enhances students' IQ levels substantially. On average, there was an increase of 9.83 points in Intelligence quotient (IQ level) among 78% students participating in the study (n=40). This improvement underscores Vidyarthi Amrit's efficacy in enhancing cognitive abilities, crucial for academic performance and cognitive function.

Antioxidant Properties: Vidyarthi Amrit is noted for its rich antioxidant content, which plays a vital role in improving brain function. Antioxidants help protect brain cells from oxidative stress and promote overall cognitive health. This makes Vidyarthi Amrit not only a brain tonic for enhancing memory and concentration but also a supportive supplement for long-term brain health.

Conclusion

Vidyarthi Amrit emerges as a scientifically validated brain tonic, offering significant benefits in enhancing memory, concentration, and overall cognitive function. Backed by clinical research demonstrating its ability to increase IQ levels and its antioxidant properties, Vidyarthi Amrit provides a valuable support for students and individuals seeking to optimize brain performance. With its proven efficacy and safety, Vidyarthi Amrit stands as a reliable choice for improving cognitive abilities and supporting brain health.

Glucomadouble-blind, placebo-controlled trial conducted at the All India Institute of Medical Sciences (AIIMS), New Delhi, a pilot study conducted at King George's Medical University (KGMU), Lucknow, and two additional clinical studies independently verifying its efficacy. These studies collectively underscore Glucomap's effectiveness in managing blood glucose levels and improving overall metabolic health.

Glucomap stands out as a promising solution in the realm of diabetes management. Its ability to significantly reduce fasting and postprandial glucose levels, HbA1c, and triglycerides, along with its efficacy in patients with uncontrolled diabetes, makes it a valuable addition to current therapeutic options. These findings pave the way for further research and potential widespread clinical application, offering hope to millions of individuals managing diabetes.